Navigation Links
High Blood Pressure May Add to Alzheimer's Risk, Study Finds

By Steven Reinberg
HealthDay Reporter

MONDAY, March 18 (HealthDay News) -- High blood pressure in people with a genetic risk for Alzheimer's disease may spur development of brain plaque, a hallmark of the age-related brain disorder, a new study suggests.

The findings suggest yet another reason for keeping blood pressure, also known as hypertension, under control, the researchers said.

"Maintaining good vascular health by avoiding or controlling diseases like hypertension has important benefits beyond keeping your heart healthy. It may promote good brain health as we age," said lead researcher Karen Rodrigue, an assistant professor of behavioral and brain sciences at the University of Texas at Dallas.

This is especially so for people who are genetically at risk for Alzheimers disease, the study suggested. "Keeping good vascular health may limit or delay the brain changes associated with Alzheimer's disease and other aging-related neurological deterioration," Rodrigue said.

No cure exist for Alzheimer's, and experts anticipate that by 2050 the number of Americans with the brain disease will approach 14 million if no progress is made.

The study of nearly 120 adults found that people with this genetic risk factor for Alzheimer's disease -- called an apolipoprotein E 4 allele -- plus untreated high blood pressure have more beta-amyloid plaques compared to those with just one or neither of these risk factors.

One expert said the findings have important implications.

"This is good news," said Dr. Sam Gandy, associate director of the Mount Sinai Alzheimer's Disease Research Center in New York City.

"This means that yet another simple intervention -- here, blood pressure control, but think also of physical exercise -- can have an important impact on dementia risk and rate of progression," Gandy said. "We must not overlook these simple effective interventions while developing new therapies."

For the study, which was published online March 18 in the journal JAMA Neurology, the researchers looked at 118 people with normal brain function who were between 47 and 89 years old. They divided the patients into those with high blood pressure and those without high blood pressure, and those with and without the genetic risk factor for Alzheimer's. The participants also were given brain scans to look for plaques.

The researchers found people with both high blood pressure and the genetic risk factor had significantly more brain plaque than those with only one or no risk factors.

Moreover, those with the highest blood pressure and the gene mutation tended to have the most plaque, they found. The study did not, however, prove a cause-and-effect relationship between high blood pressure, this genetic mutation and increased brain plaque.

High blood pressure is highly responsive to lifestyle changes and medical treatment, and it may provide a future target for delaying or preventing Alzheimer's disease, the researchers noted.

More information

For more information on Alzheimer's disease, visit the Alzheimer's Association.

SOURCES: Karen Rodrigue, Ph.D., assistant professor, behavioral and brain sciences, University of Texas at Dallas; Sam Gandy, M.D., associate director, Mount Sinai Alzheimer's Disease Research Center, New York City; March 18, 2013, JAMA Neurology, online

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Experts Question Use of Ankle Blood Pressure to Gauge Heart Risks
2. Study Probes Use of Filter Device to Stop Deadly Blood Clots
3. Blood levels of fat cell hormone may predict severity of migraines
4. Vitamin D Supplements Tied to Lower Blood Pressure in Blacks
5. Blacks With Kidney Disease Should Watch for Blood Pressure Shifts: Study
6. Clot Buster Safe for Stroke Patients on Blood Thinners: Study
7. Cord blood effective alternative to matched donor stem cells for kids with rare disorder
8. Vitamin D may lower blood pressure in African-Americans
9. Blood Test Plus Targeted Care May Stop Heart Failure Before It Starts
10. Store donated blood for more than 3 weeks? Say NO (nitric oxide)
11. Drugs targeting blood vessels may be candidates for treating Alzheimers
Post Your Comments:
Related Image:
High Blood Pressure May Add to Alzheimer's Risk, Study Finds
(Date:6/26/2016)... Charlotte, NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind ... able to be personalized through a fitness app. The fitness app plans to fix the ... solutions currently only offer a one size fits all type program , They ...
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 ... brings up a new, often overlooked aspect of head lice: the parasite’s ability to live ... not a common occurrence, but a necessary one in the event that lice have simply ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has dedicated ... has implemented orthobiologic procedures as a method for treating his patients. The procedure ... doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may ... to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To ... for healthy coping following a traumatic event. , Trauma sufferers tend to feel a ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, ... Elite. The attorneys chosen by their peers for this recognition are considered among the ... Traurig Shareholders received special honors as members of this year’s Legal Elite Hall of ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Research and Markets has announced ... Forecast to 2022" report to their offering. ... the patients with kidney failure, it replaces the function of ... patient,s blood and thus the treatment helps to keep the ... balance. Increasing number of ESRD patients & ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: ... 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) assay ... sepsis or septic shock. With this clearance, Roche is ... a fully integrated solution for sepsis risk assessment and ... with bacterial infection and PCT levels in blood can ...
(Date:6/23/2016)... Bracket , a leading clinical trial technology and specialty ... Bracket eCOA (SM) 6.0, at the 52 nd ... in Philadelphia , Pennsylvania.  A demonstration of ... its kind to fully integrate with RTSM, will be held ... a flexible platform for electronic clinical outcomes assessments that is ...
Breaking Medicine Technology: